Umberto Ficola
Via San Lorenzo 312/D
Palermo, 90146, Italy
Palermo, 90146, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Erratum: Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 26, 2025
Whole-body MRI radiomics model to predict relapsed/refractory Hodgkin Lymphoma: A preliminary study.
Whole-body MRI radiomics model to predict relapsed/refractory Hodgkin Lymphoma: A preliminary study.
Journal: Magnetic resonance imaging
Published: July 24, 2021
Consolidation Radiotherapy Could Be Safely Omitted in Advanced Hodgkin Lymphoma With Large Nodal Mass in Complete Metabolic Response After ABVD: Final Analysis of the Randomized GITIL/FIL HD0607 Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 18, 2020
Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 24, 2018
124I-MIBG: a new promising positron-emitting radiopharmaceutical for the evaluation of neuroblastoma.
Journal: Nuclear medicine review. Central & Eastern Europe
Published: July 31, 2015
Comparison between whole-body MRI with diffusion-weighted imaging and PET/CT in staging newly diagnosed FDG-avid lymphomas.
Journal: European journal of radiology
Published: May 28, 2015
WIDEN: A tool for medical image management in multicenter clinical trials.
Journal: Clinical trials (London, England)
Published: April 09, 2014
Is %ΔSUVmax a useful indicator of survival in patients with advanced nonsmall-cell lung cancer?
Journal: TheScientificWorldJournal
Published: August 07, 2013
A comparison between ¹⁸F-FDG PET/CT imaging and biological and radiological findings in restaging of hepatoblastoma patients.
Journal: BioMed research international
Published: April 29, 2013
Prediction of 2 years-survival in patients with stage I and II non-small cell lung cancer utilizing (18)F-FDG PET/CT SUV quantification.
Journal: Radiology and oncology
Published: October 15, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026